OTCMKTS:CRGS CurAegis Technologies (CRGS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CurAegis Technologies Stock (OTCMKTS:CRGS) 30 days 90 days 365 days Advanced Chart Get CurAegis Technologies alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume5,900 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCurAegis Technologies, Inc. does not have significant operations. Previously, it was engaged in the development and marketing of technologies in the areas of wellness, safety, and power. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York. On August 4, 2021, an involuntary petition for liquidation under Chapter 7 was filed against CurAegis Technologies, Inc. in the U.S. Bankruptcy Court for the Western District of New York. On August 31, 2021, the involuntary petition was approved by the Court.Read More… Receive CRGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CurAegis Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CRGS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com CRGS Stock Analysis - Frequently Asked Questions How were CurAegis Technologies' earnings last quarter? CurAegis Technologies, Inc. (OTCMKTS:CRGS) posted its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.02) EPS for the quarter. How do I buy shares of CurAegis Technologies? Shares of CRGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CurAegis Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that CurAegis Technologies investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Acasti Pharma (ACST), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE) and Ampliphi Biosciences (APHB). Company Calendar Last Earnings5/13/2020Today4/26/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Motor vehicle parts & accessories Sub-IndustryAutomobiles And Trucks Current SymbolOTCMKTS:CRGS Previous SymbolOTCMKTS:TOVC CIK1063197 Webwww.curaegis.com Phone(585) 254-1100Fax585-254-1105Employees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:CRGS) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CurAegis Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CurAegis Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.